CDER - Office of Pharmaceutical Science - Organization - Text version

The following header reflects the organizational hierarchy.

FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF PHARMACEUTICAL SCIENCE

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

Main Tele:      301-796-2400
Fax:                301-796-9996
Address:         WO Bldg 51 Rm: 4184
                       10903 New Hampshire Ave.
                       Silver Spring, MD 20993

The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Drug Evaluation and Research, Office of Pharmaceutical Science organization structure depicting all the organizational structures reporting to the Office Director.  These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

Each organizational component will be depicted in the following standard format:

Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.

DIRECTOR
Keith Webber, Ph.D. (Acting)

DEPUTY DIRECTOR
Keith Webber, Ph.D.
(DKKNS)

Reports Directly to the Director:

OFFICE OF GENERIC DRUGS
DIRECTOR
Gregory P. Geba, M.D., M.P.H.

Reports Directly to the Director, Office of Generic Drugs:

DEPUTY DIRECTOR
Robert West
(DKKNSB)

Reports Directly to the Director:

OFFICE OF NEW DRUG QUALITY ASSESSMENT
DIRECTOR
Christine Moore, Ph.D. (Acting)

Reports Directly to the Director, Office of New Drug Quality Assessment:

DEPUTY DIRECTOR REVIEW AND OPERATIONS
Elaine Morefield, Ph.D.

DEPUTY DIRECTOR SCIENCE AND POLICY
Richard Lostritto, Ph.D. (Acting)
(DKKNSC)

Reports Directly to the Director:

OFFICE OF TESTING AND RESEARCH
DIRECTOR
Vincent Vilker, Ph.D.
(DKKNSD)

OFFICE OF BIOTECHNOLOGY PRODUCTS
DIRECTOR
Steven Kozlowski, M.D.

Reports Directly to the Director, Office of Biotechnology Products:

DEPUTY DIRECTOR
Jeffrey Baker, Ph.D.
(DKKNSE)

Approved by the FDA Reorganization Coordinator and Principal Delegations Control Officer